Creates orally administered nucleoside inhibitors designed to target retrotransposons and reverse chronic neurodegeneration.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Transposon develops a clinical-stage biopharmaceutical platform of orally administered therapies engineered to combat neurodegenerative, oncology, and aging-related diseases. The pipeline focuses heavily on novel nucleoside reverse transcriptase inhibitors designed to silence retrotransposon expression and suppress viral replication markers within the human genome. By targeting the underlying pathways of neuroinflammation, cellular dysfunction, and tumor-defined genetic signatures, the system works to restore cognitive stability and deliver personalized cancer treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Transposon Management Team
Investors
Canaan Partners
Transposon Valuations & Financials
View real-time NPM data on Transposon stock including daily Transposon stock price estimates, valuation history, and historical share price information. Access Transposon financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Transposon pricing across six independent market signals. Looking for private company due diligence data sources on Transposon? Get in touch to learn more.
Similar Companies
like Transposon
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Sentra
Cybersecurity
Cloud-based platform that discovers sensitive data vulnerabilities, detects misconfigurations, and remedies security risks in public environments.
RxAnte
Healthcare & Life Sciences
Uses predictive analytics and clinical programs to improve medication use, adherence, and healthcare outcomes for health plans.
Frontier Risk Group
FinTech
Offers cannabis‑industry businesses streamlined access to specialized insurance solutions that address unique regulatory and operational risks.
Interdict Bio
Healthcare & Life Sciences
Expert innovator enabling targeted protein synthesis modulation for disease therapies using context-specific small molecules.
Zuma
AI & Machine Learning
Automates leasing, collections, and prospect engagement across the full resident lifecycle.
RecoveryOne
Healthcare & Life Sciences
Digital platform delivering personalized rehabilitation programs with guided exercises and expert support for injury recovery and pain management.
Leaf Logistics
Commerce & Marketplaces
A logistics technology company that facilitates collaboration among shippers, carriers, and brokers to optimize freight scheduling and reduce waste.
Nisos
Cybersecurity
Provides intelligence and security solutions to identify, monitor and respond to cyber threats through advanced analytics and real-time monitoring.
FAQ
We have answers
Transposon stock does not trade on public stock exchanges. Transposon stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Transposon stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Transposon Stock does not trade on public stock exchanges. In order to sell Transposon shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Transposon does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Transposon share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Transposon stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Transposon stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Transposon stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Transposon is a private company and has not had an IPO. There is currently no Transposon IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Transposon IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
